Abstract
Aim of this study was to define oral dose range and treatment regimen of a pharmaceutically well-standardized Withania somnifera root extract (WS) potentially useful for treatments of diabetes-associated comorbidities. Normal and diabetic male mice were treated daily with graded oral doses of WS for 10 consecutive days. On the 1st, 5th, 7th, and 10th days of treatments, the animals were subjected to a foot shock stress-triggered hyperthermia tests. Changes in body weights and basal core temperatures of experimental animals during the course of the experiments were also recorded. In addition, plasma glucose, insulin, and cortisol levels and weights of adrenal glands and spleen of diabetic animals were quantified after 10 daily WS doses. No statistically significant effects of a single oral dose of WS on any of the quantified parameters were observed even after its highest oral dose (400 mg/kg) tested. However, dose and duration of treatment dependant protective effects of WS against body weight losses and elevated core temperatures caused by daily handling and intermittent foot shock stress, as well as against stress-triggered transient hyperthermia were observed in both normal and diabetic mice after its repeated daily doses. Dose dependant efficacy of the extract against elevated plasma glucose, insulin, and cortisol levels, and alterations in adrenal gland and spleen weights of diabetic animals were apparent after its 10 daily doses. Reported observations add further experimental evidence justifying traditionally known medicinal uses of Withania somnifera for treatment of mental health problems commonly associated with numerous lifestyle-related chronic diseases.
Keywords: Ashwagandha, adaptogens, diabetes, foot-shock, hyperthermia, stress, Withania somnifera.
Graphical Abstract
Current Traditional Medicine
Title:Reverse Ayurvedic Pharmacology of Ashwagandha as an Adaptogenic Anti-Diabetic Plant: A Pilot Study
Volume: 1 Issue: 1
Author(s): Ajit K. Thakur, Amitabha Dey, Shyam S. Chatterjee and Vikas Kumar
Affiliation:
Keywords: Ashwagandha, adaptogens, diabetes, foot-shock, hyperthermia, stress, Withania somnifera.
Abstract: Aim of this study was to define oral dose range and treatment regimen of a pharmaceutically well-standardized Withania somnifera root extract (WS) potentially useful for treatments of diabetes-associated comorbidities. Normal and diabetic male mice were treated daily with graded oral doses of WS for 10 consecutive days. On the 1st, 5th, 7th, and 10th days of treatments, the animals were subjected to a foot shock stress-triggered hyperthermia tests. Changes in body weights and basal core temperatures of experimental animals during the course of the experiments were also recorded. In addition, plasma glucose, insulin, and cortisol levels and weights of adrenal glands and spleen of diabetic animals were quantified after 10 daily WS doses. No statistically significant effects of a single oral dose of WS on any of the quantified parameters were observed even after its highest oral dose (400 mg/kg) tested. However, dose and duration of treatment dependant protective effects of WS against body weight losses and elevated core temperatures caused by daily handling and intermittent foot shock stress, as well as against stress-triggered transient hyperthermia were observed in both normal and diabetic mice after its repeated daily doses. Dose dependant efficacy of the extract against elevated plasma glucose, insulin, and cortisol levels, and alterations in adrenal gland and spleen weights of diabetic animals were apparent after its 10 daily doses. Reported observations add further experimental evidence justifying traditionally known medicinal uses of Withania somnifera for treatment of mental health problems commonly associated with numerous lifestyle-related chronic diseases.
Export Options
About this article
Cite this article as:
K. Thakur Ajit, Dey Amitabha, S. Chatterjee Shyam and Kumar Vikas, Reverse Ayurvedic Pharmacology of Ashwagandha as an Adaptogenic Anti-Diabetic Plant: A Pilot Study, Current Traditional Medicine 2015; 1 (1) . https://dx.doi.org/10.2174/2215083801999150527115205
DOI https://dx.doi.org/10.2174/2215083801999150527115205 |
Print ISSN 2215-0838 |
Publisher Name Bentham Science Publisher |
Online ISSN 2215-0846 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Adrenocortical Crisis Triggered by Levothyroxine in an Unrecognized Autoimmune Polyglandular Syndrome Type-2: A Case Report with Review of the Literature
Current Drug Safety Physical Function and Exercise in Older Patients with Cardiovascular and Respiratory Conditions
Current Pharmaceutical Design Epigenetic control of cardiovascular health by nutritional polyphenols involves multiple chromatin-modifying writer-reader-eraser proteins
Current Topics in Medicinal Chemistry Nitric Oxide and Dietary Factors: Part II Cholesterol, Fat, Amino Acids,Proteins and Carbohydrate
Vascular Disease Prevention (Discontinued) Radioprotective Effect of Gliclazide as an Anti-Hyperglycemic Agent Against Genotoxicity Induced by Ionizing Radiation on Human Lymphocytes
Cardiovascular & Hematological Agents in Medicinal Chemistry Establishing Maternal Tolerance: The Role of Regulatory T Cells (Tregs) in Pregnancy and Pathophysiology of Preeclampsia
Current Women`s Health Reviews The Changing Face of HIV/AIDS in Treated Patients
Current HIV Research Novel Antidiabetic Agents: Cardiovascular and Safety Outcomes
Current Pharmaceutical Design Vitiligo and Allergic Complications from Orthopaedic Joint Implants: The Role of Benzoyl Peroxide
Recent Patents on Inflammation & Allergy Drug Discovery Top Three Pharmacogenomics and Personalized Medicine Applications at the Nexus of Renal Pathophysiology and Cardiovascular Medicine
Current Pharmacogenomics and Personalized Medicine Chemical and Clinical Development of Darinaparsin, a Novel Organic Arsenic Derivative
Anti-Cancer Agents in Medicinal Chemistry Determinants of Use of Long-term Continuous Electrocardiographic Monitoring for Acute Ischemic Stroke Patients without Atrial Fibrillation at Baseline
Current Neurovascular Research The Potential Role of Antioxidants in Metabolic Syndrome
Current Pharmaceutical Design Oral Factor Xa (FXa) Inhibitors for Treatment of Heparin-induced Thrombocytopenia (HIT)
Current Drug Therapy Expression and Characterisation of Recombinant Molecules in Transgenic Soybean
Current Pharmaceutical Design High-Density Lipoprotein and Low-Density Lipoprotein Subfractions in Patients with Chronic Kidney Disease
Current Vascular Pharmacology Perspectives on Medicinal Properties of Mangiferin
Mini-Reviews in Medicinal Chemistry Uncovering the Diversification of Tissue Engineering on the Emergent Areas of Stem Cells, Nanotechnology and Biomaterials
Current Stem Cell Research & Therapy Female Infertility and Assisted Reproduction: Impact of Oxidative Stress-- An Update
Current Women`s Health Reviews C-Abl Inhibition; A Novel Therapeutic Target for Parkinson's Disease
CNS & Neurological Disorders - Drug Targets